Stocks股票 / Health Care / SDGR
SDGR US listed · USD美股 · 美元
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science.Schrödinger, Inc. 是一家国际科学软件和生物技术公司,专注于开发用于药物发现和材料科学的计算工具和软件。
Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-07-21Earnings财务业绩
next report下次财报 2026-08-05Estimates being cut预期下调
Financials财务数据
fiscal years财年Leverage杠杆
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向: -$0.3M net (0 buyers, 8 sellers)-$0.3M 净值(0 买家,8 卖家)
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Gates Foundation Trust | D | Holding持有 | 0.2% | 2026-03-31 |
| Perceptive Advisors | A | exitexit | 0.0% | 2026-03-31 |
Signal history信号历史
engine events引擎事件Company profile公司档案
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science.Schrödinger, Inc. 是一家国际科学软件和生物技术公司,专注于开发用于药物发现和材料科学的计算工具和软件。
- Margin compression despite revenue growth
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -8.6% | -0.9% |
| 1 Month近1月 | -4.8% | -0.6% |
| 3 Months近3月 | +16.5% | +5.4% |
| 6 Months近6月 | -8.6% | +8.6% |
| Year to date年初至今 | -16.6% | +8.9% |
| 1 Year近1年 | -30.1% | +19.2% |
| 3 Years近3年 | -72.1% | +69.9% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $108M | $138M | $181M | $217M | $208M | $256M |
| EPS每股收益 | $-0.41 | $-1.42 | $-2.10 | $0.54 | $-2.57 | $-1.41 |
| Free cash flow自由现金流 | $14M | $-78M | $-128M | $-150M | $-165M | $12M |
| Gross margin毛利率 | 58.7% | 47.6% | 55.8% | 64.9% | 63.6% | 55.7% |
| Net margin净利率 | -22.6% | -72.8% | -82.4% | 18.8% | -90.2% | -40.4% |
| FCF margin自由现金流利润率 | 13.2% | -56.4% | -70.6% | -69.3% | -79.3% | 4.9% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量:盈利有现金支撑
- Working capital: receivables +164% vs sales +137% — receivables outpacing sales, revenue-quality risk营运资本:应收 +164% 对销售 +137%——应收快于销售,营收质量风险
- Pricing power: gross margin −3.0pts over 6 years定价能力:毛利率 6 年下降 3.0 个百分点
- Capital discipline: disciplined growth, returning cash资本纪律:增长克制、回报股东
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Estimate revisions预期修正
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Gates Foundation Trust | D | Holding持有 | 0.2% | $79M |
| Perceptive Advisors | A | Exited清仓 | 0.0% | $4M |
Fund positioning基金持仓概览
Insiders & shorts内部人与空头
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 33% | -23.8% | 3 |
| Feb2月 | 0% | -10.6% | 3 |
| Mar3月 | 33% | -5.3% | 3 |
| Apr4月 | 67% | +6.1% | 3 |
| May5月 | 33% | -11.7% | 3 |
| Jun6月 | 50% | +8.4% | 4 |
| Jul7月 | 75% | +6.0% | 4 |
| Aug8月 | 0% | -3.5% | 3 |
| Sep9月 | 33% | -11.9% | 3 |
| Oct10月 | 33% | -4.6% | 3 |
| Nov11月 | 67% | +27.5% | 3 |
| Dec12月 | 67% | +2.8% | 3 |